Reovirus type 1, after intravenous inoculation in the adult mouse, is secreted via bile into the intestine in an infectious form. Although reovirus type 1 is rapidly removed from systemic circulation by the liver and the lung, very few hepatocytes express reovirus antigen during infection. In intestinal cells, reovirus replicates selectively in the crypts. This site preference may be due to active cell proliferation in the crypts. We hypothesized that the state of the cell may affect virus replication and tested this hypothesis by using chemical and surgical means to increase hepatic mitotic activity. Adult mice were treated with carbon tetrachloride or surgical trauma, inoculated with reovirus type 1 intravenously, and subsequently killed. Virus antigen was identified using a highly specific immunohistochemical technique. Liver sections were stained using immunoperoxidase with specific rabbit antireovirus antibody. Hepatotoxin and surgical trauma increase reovirus antigen detection in both Kupffer cells and hepatocytes. Only the sequential administration of CCI1 and virus caused mortality at doses sublethal for each alone. These data demonstrate a synergism between hepatic injury and reovirus which results in a significant increase in the magnitude of viral infection and contributes to mortality. Such synergism may be important in idiopathic liver disease. (J. Clin. Invest. 1990Invest. . 86:1038Invest. -1045 
Introduction
Reoviruses infect animals, including man, via an enteric route (1, 2) . After entry through M cells, reovirus may infect other organ systems (3) . The site and outcome of reovirus disease depends on the serotype of the virus, the inoculum size, and the age of the host (4) (5) (6) . In individual organs, site specific infection has been recognized (5, 7) . We have shown that reovirus type 1 infects crypt cells within the ileum, but mature villus cells do not become productively infected (5) . For both crypt and villus epithelial cells, virus-specific receptors are present on the basolateral surface (8) . Therefore, virus infec-tion is not dependent merely upon the capacity of the virus to bind to the intestinal cell. This finding suggests that reovirus replication is restricted to replicating epithelial cells at a step after binding of virus.
After entry into the host, systemic virus is rapidly cleared by the lung and the liver (9) . Our studies have shown that reovirus type 1 can pass into the bile in an infectious form during systemic infection (10) . However, few hepatocytes have evidence of antigen at times when virus can be found within the bile, and hepatic infection has not been reported as a significant component of systemic infection with reovirus type 1/L in suckling mice (1 1) .
Reovirus causes hepatobiliary infection in the neonatal mouse, with hepatocellular necrosis ( 12) . Reovirus type 1 replication within the adult liver may be restricted in a manner analogous to intestinal epithelial cells. Since the mature liver has a low mitotic index, an enhancement of hepatocellular replication might increase reovirus antigen expression.
To examine whether the state of the hepatocyte affects reovirus replication an hepatotoxin, carbon tetrachloride (CC14) or surgery were used to increase the mitotic index of hepatocytes. Carbon tetrachloride causes a P-450-mediated lipid peroxidation of the endoplasmic reticulum and also results in covalent binding of CC14 metabolites, resulting in a centrizonal necrosis and subsequent regeneration (13) . The replication begins within 12 h and peaks at 48-72 h after CC14 administration (14) (15) (16) . Hepatic resection of 30-70% results in a marked increase in the hepatic mitotic index from 15-36 h later (17) , without zonal necrosis. Both methods have been shown to result in regeneration, production of alpha-fetoprotein, polyamines, changes in hormone receptors, and expression of cellular oncogenes. Similarly, induced focal injury has been shown to increase the proliferation of local Ito cells and hepatocytes adjacent to the areas of damage, but not in other uninjured lobes (18) .
The experiments presented here demonstrate that these methods of hepatic insult increase the expression of reovirus antigen in the liver. Furthermore, pretreatment of animals with sublethal doses of CCI4 and reovirus type 1 results in a profound increase in mortality, which is uniquely dependent on the time course of their administration.
Methods

Mice
Adult female A/J mice (Jackson Laboratory, Bar Harbor, ME), 5-7 wk old, were fed a house diet (Ralston-Purina Corp., St. Louis, MO) and water ad lib. and maintained in an animal facility with a controlled light/dark cycle. Viral experiments were conducted in separate facilities, and there was no evidence of humoral response to reovirus in the mice before experimentation.
Purification ofreovirus
Reovirus type 1/Lang (1/L) was obtained and prepared as previously described (19). For mouse inoculation, a stock of reovirus that was passed twice in L cells was purified by substituting ultrasonic disruption (Ultrasonic 200; Branson Sonifiers, Danbury, CT) for cell homogenization in a modification of previously described techniques (20) . The ratio of viral particle to plaque-forming unit (pfu) was -100:1 (21) . Assay of viral PFU was performed as previously described (5).
Inoculation ofvirus
Mice were inoculated intravenously via the tail vein with -10" particles of reovirus type 1/L (determined by the optical density of the suspension) suspended in 0. 
Collection ofsamples and viral assay
Mice were killed and processed immediately for pathology and viral titer assay. In animals where bile was sampled, mice were first anesthetized with intraperitoneal pentobarbital (50 mg/kg i.p.) and the common duct was cannulated with PE-IO tubing (Clay-Adams Div., Parsippany, NJ) for 30 min before killing. Bile was frozen and stored at -70'C before assay. Blood, duodenum, ileum, liver, spleen, and lung were collected on ice for viral assays and frozen at -70'C. Specimens of intestinal tissues were collected and assayed as previously described (5 (23) . Sections were developed with diaminobenzidene chromogen, with hematoxylin solution for counterstaining.
Using Sigma Scan (Jandel, Corte Madera, CA) and a light microscope with a square marked eyepiece divided into a 10 by 10 grid, the following measurements and counts were performed: area ofeach liver section, areas of necrosis in each section, percent necrosis, and number ofhepatocytes per grid. These were used to determine the total number of viable hepatocytes. For each animal, an area containing -30,000 cells was counted. The positive immunoperoxidase cells were identified as either hepatocytes, Kupffer cells or cells of indeterminate type, and expressed per 1,000 hepatocytes.
Animal groups
Effect ofthe timing ofCC4 administration on reovirus infection. Adult A/J mice were divided into four groups (n = 12-18 per group). The control group received only reovirus, while the three experimental groups were given CC14 4, 2, or 1 d(s) before, or simultaneously with, intravenous inoculation with 109 pfu (10" particles) of reovirus type 1/L. To eliminate intergroup variability, reovirus inoculation was performed on the same day on all groups, and the time recorded as day = 0. One group of mice was killed at 2 d after inoculation for viral assays and morphometric analysis. A second group of mice (n = 18) was followed for 4 d postinoculation to monitor mortality.
Dose ofviral inoculum after CCI administration necessary to produce mortality. Mice were given CC14 2 d before an intravenous inoculation of either 109 pfu (10" particles), 108 pfu (1010 particles), or 107 pfu (109 particles) and surviving mice were killed at 4 d postinoculation. The effects of viral inoculum on morbidity, mortality, hepatic histopathology, and viral titers were recorded.
Effect ofhepatic trauma and hepatic regeneration on viral antigen expression in the liver. 16 mice underwent laparotomy with pentobarbital anesthesia. Mice were divided into three groups: (a) 50% hepatic resection, (b) blunt trauma to one lobe of liver, or (c) sham-operated control mice. Hepatic resection was performed with removal of three lobes of liver and suture ligation of the lobar pedicle. These mice received water containing 20% glucose (wt/vol) for 2 d. For the experimental mice receiving blunt trauma, the large median lobe of the liver was identified and compressed three times with a pair of blunt forceps to produce a small hematoma. For control mice, the abdomen was opened but the liver was not manipulated, and the abdomen was closed.
All three groups were then inoculated with 109 pfu of reovirus type 1/L. Two days postinoculation the mice were killed, and the entire traumatized "local" lobe and a right "distal" lobe were fixed for processing. Necrotic areas adjacent to the site of trauma were excluded from analysis.
Liverfunction tests
Serum was obtained from groups of five mice inoculated with virus, virus plus CC14, or CC14 alone at 6-h intervals after toxin and virus challenge. Liver functions tests included albumin, alanine aminotransferase (ALT),' aspartate aminotransferase (AST), bilirubin, and total protein, and were performed on Ektachem autoanalyzer (EastmanKodak Co., Rochester, NY) using standard automatic methods.
Statistics
Groups of mice were analyzed by analysis of variance and independent two tailed t tests. Liver function tests obtained from serum specimens from groups of mice were analyzed for significance by Chi-square. Statistical significance was P < 0.05.
Results
Hepatotoxin exposure increases reovirus antigen expression in both Kupifer cells and hepatocytes. In the livers of mice given virus alone, there was no histologic hepatitis, and 1% of hepatocytes expressed reovirus antigen (Fig. 1, A and B ). Mice treated with CCL, alone demonstrated zone 3 necrosis, but no immunoperoxidase positive staining. All mice receiving CCL1 and virus showed a significant increase in the expression of reovirus antigen in both hepatocytes (Figs. 1 D and 2 A) and Kupffer cells (Fig. 2 B) . Significant differences in hepatocyte immunoperoxidase staining existed among all experimental groups compared to the control group (P < 0.0001). In addition, the group of mice treated with CC1 2 d before inoculation of virus was significantly different when compared to the other experimental groups (P < 0.02, Fig. 2 A) . The results for 1. Abbreviations used in this paper: ALT, alanine aminotransferase; AST, aspartate aminotransferase; CC14, carbon tetrachloride. Kupffer cells were similar to those seen in hepatocytes, with the maximal increase in reovirus antigen positive Kupffer cells being present in mice pretreated with CCI4 2 d before virus inoculation (P < 0.001 and P < 0.01 versus controls and other experimental groups, respectively, Fig. 2 B) .
Reovirus virions are present in Kupffer cells by electron microscopic analysis. By electron microscopy, intact virions could be readily identified in Kupffer cells of mice receiving pretreatment CCI4 2 d before reovirus administration (Fig. 3 A). Despite a 10-fold higher magnitude of antigen-positive hepatocytes as compared with Kupffer cells, it was difficult to identify intact virions in hepatocytes. In CCI4-treated livers, hepatocytes were, however, identified that demonstrate unusual cytoplasmic inclusions containing coarse filamentous and/or floccular material. (Fig. 3 B) . Titers ofinfectious reovirus type I are increased with hepatotoxin exposure. With respect to viral titers, there was no difference in the low titers of reovirus in the spleen, colon, ileum, blood, or lung, or in the relatively high titer found in bile between experimental groups and controls (Table I) . However, there was a 1.8 log10 increase in the viral titers assayed from experimental mouse livers (P < 0.01, (Fig. 4, A and B, respectively) . In these groups, the magnitude of the effect was similar to that seen with CC1I.
Hepatotoxin exposure increases morbidity and mortality. All mice treated with CCI4 lost similar amounts of weight in the first 2 d after administration. Mice treated with CCI 2 d before virus had the most dramatic weight loss, with the survivors being significantly lighter than the mice in the other groups (P < 0.01, data not shown).
Mortality was observed only in the mice that received CCLI 1 or 2 d before 5 X 108 to 109 pfu inoculation, with 75-100% of mice dying, depending upon experiment. Other sequences never resulted in mortality.
Liver function tests performed on sera from groups of mice that received reovirus type 1 plus CC14 had significantly higher AST and ALT levels (P < 0.0001) at 30 h after virus infection than mice that received CC14 or reovirus alone (Table II) . Total protein, albumin and bilirubin were not significantly different between the groups at multiple time points (6-30 h) after virus infection.
Since reovirus antigen detection was greatest in mice pretreated with CCI 2 d before inoculation, three groups of CCI4 pretreated mice were inoculated with either I07, 108, or 109 pfu reovirus and were observed for 4 d. A significant increase in mortality was only seen in the group of mice receiving the highest inoculum. In this group, mortality began at day 2 and peaked at day 3. Observation of mice for as long as 2 wk after inoculation did not result in any increase in mortality.
Discussion
Despite the previous demonstrations that the liver plays a role in clearance of systemic reovirus (9) , and that the virus is excreted in bile (10) Even with the increased expression of viral antigen, visual- ized by immunoperoxidase staining, we were unable to identify intact virions in hepatocytes by electron microscopy. We suspect the unusual cytoplasmic inclusions demonstrated in Fig. 3 B may represent viral protein, and are investigating this possibility via immunoelectron microscopy. These results suggest that reovirus antigen expression may not represent complete assembly of infectious virus in some cell types (i.e., hepatocytes). Furthermore, this suggests that the increased titers of virus found in mouse livers stimulated to express reovirus antigen by co-administration of CC14 may be due to enhanced production of virions by Kupffer cells.
There are a number of mechanisms that might be responsible for the enhanced expression of reovirus associated with these liver perturbations. It is unlikely that alterations in membrane fluidity or permeability associated with CC14 accounts for enhanced reovirus antigen expression since the toxin was effective even when given 4 days prior to virus.
Other mechanisms to account for increases in reovirus expression include the following: (a) that increases in the number or avidity of cell membrane receptors for reovirus occur with hepatic insult; or (b) that reovirus antigen expression requires a replicating or activated cell. In vitro, Duncan et al. (24) have suggested that transformed cells are more capable of replicating virus than nontransformed cells. Their experiments suggested that reovirus infection might be enhanced during increased cell turnover, in a manner not related to virus receptor alterations. Studies are in progress to examine which factors influence reovirus replication and antigen expression in vivo.
The basis of the enhanced mortality in one group of CCl4/ reovirus treated mice is similarly unclear. A synergism between non-lethal doses of reovirus type 1/L (6) and CC14 resulted in lethal disease only when virus was given 1 or 2 d after toxin. This time course coincides with the known peak of mitotic activity in hepatocytes after a single dose of CCl4 (14) . (34) (35) (36) , although the significance of these findings is unclear. This question should perhaps be revisited, since our findings raise the theoretic possibility that infection with reovirus, or some other nonpathogenic virus, may induce pathologic lesions in the liver of individuals with acute or chronic hepatic insults (e.g., alcohol injury).
